BAKER BROS ADVISORS LLC Insider Trading $GHDX GENOMIC HEALTH INC
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).
BAKER BROS ADVISORS LLC in GENOMIC HEALTH INC
Trading Symbol: GHDXIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 165,980 shares
Current Value: $4,562,790
Latest Transaction: Oct 03 2019
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC in GENOMIC HEALTH INC
Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 24 | 2,012 | 212,431 | 212.5 K to 212.4 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 2 | 168 | 53,513 | 53.5 K to 53.5 K (0.00 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 27 | 2,264 | 232,477 | 232.5 K to 232.5 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 9,301 | 789,121 | 11,249,380 | 11.3 M to 11.2 M (-0.08 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 1,428 | 121,155 | 1,761,320 | 1.8 M to 1.8 M (-0.08 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 246 | 20,871 | 337,057 | 337.3 K to 337.1 K (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 143 | 12,132 | 212,455 | 212.6 K to 212.5 K (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 11 | 933 | 53,515 | 53.5 K to 53.5 K (-0.02 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 159 | 13,490 | 232,504 | 232.7 K to 232.5 K (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 21,423 | 1,913,901 | 11,258,681 | 11.3 M to 11.3 M (-0.19 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 3,289 | 293,835 | 1,762,748 | 1.8 M to 1.8 M (-0.19 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 567 | 50,655 | 337,303 | 337.9 K to 337.3 K (-0.17 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 329 | 29,392 | 212,598 | 212.9 K to 212.6 K (-0.15 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 25 | 2,233 | 53,526 | 53.6 K to 53.5 K (-0.05 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 367 | 32,787 | 232,663 | 233 K to 232.7 K (-0.16 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 30,555 | 2,601,670 | 11,280,104 | 11.3 M to 11.3 M (-0.27 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 4,692 | 399,510 | 1,766,037 | 1.8 M to 1.8 M (-0.26 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 809 | 68,884 | 337,870 | 338.7 K to 337.9 K (-0.24 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 470 | 40,019 | 212,927 | 213.4 K to 212.9 K (-0.22 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 37 | 3,150 | 53,551 | 53.6 K to 53.6 K (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 522 | 44,447 | 233,030 | 233.6 K to 233 K (-0.22 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 36,174 | 3,102,970 | 11,310,659 | 11.3 M to 11.3 M (-0.32 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 5,554 | 476,417 | 1,770,729 | 1.8 M to 1.8 M (-0.31 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 957 | 82,091 | 338,679 | 339.6 K to 338.7 K (-0.28 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 555 | 47,607 | 213,397 | 214 K to 213.4 K (-0.26 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 42 | 3,603 | 53,588 | 53.6 K to 53.6 K (-0.08 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 620 | 53,183 | 233,552 | 234.2 K to 233.6 K (-0.26 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 3,663 | 319,780 | 11,346,833 | 11.4 M to 11.3 M (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 562 | 49,063 | 1,776,283 | 1.8 M to 1.8 M (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 97 | 8,468 | 339,636 | 339.7 K to 339.6 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 56 | 4,889 | 213,952 | 214 K to 214 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 4 | 349 | 53,630 | 53.6 K to 53.6 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 63 | 5,500 | 234,172 | 234.2 K to 234.2 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 4,306 | 380,544 | 11,350,496 | 11.4 M to 11.4 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 661 | 58,416 | 1,776,845 | 1.8 M to 1.8 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 114 | 10,075 | 339,733 | 339.8 K to 339.7 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 66 | 5,833 | 214,008 | 214.1 K to 214 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 5 | 442 | 53,634 | 53.6 K to 53.6 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 74 | 6,540 | 234,235 | 234.3 K to 234.2 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 15,798 | 1,326,160 | 11,354,802 | 11.4 M to 11.4 M (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 2,425 | 203,566 | 1,777,506 | 1.8 M to 1.8 M (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 418 | 35,089 | 339,847 | 340.3 K to 339.8 K (-0.12 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 242 | 20,315 | 214,074 | 214.3 K to 214.1 K (-0.11 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 18 | 1,511 | 53,639 | 53.7 K to 53.6 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 271 | 22,749 | 234,309 | 234.6 K to 234.3 K (-0.12 %) |
Oct 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 70.18 | 284 | 19,931 | 340,265 | 340 K to 340.3 K (+0.08 %) |
Oct 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 70.18 | 284 | 19,931 | 11,370,600 | 11.4 M to 11.4 M (0.00 %) |
Oct 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 70.18 | 284 | 19,931 | 1,779,931 | 1.8 M to 1.8 M (+0.02 %) |
Oct 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 70.18 | 284 | 19,931 | 53,657 | 53.4 K to 53.7 K (+0.53 %) |
Oct 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 70.18 | 284 | 19,931 | 214,316 | 214 K to 214.3 K (+0.13 %) |
Oct 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 70.18 | 284 | 19,931 | 234,580 | 234.3 K to 234.6 K (+0.12 %) |
Jul 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 50.40 | 396 | 19,958 | 339,981 | 339.6 K to 340 K (+0.12 %) |
Jul 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 50.40 | 396 | 19,958 | 11,370,316 | 11.4 M to 11.4 M (0.00 %) |
Jul 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 50.40 | 396 | 19,958 | 1,779,647 | 1.8 M to 1.8 M (+0.02 %) |
Jul 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 50.40 | 396 | 19,958 | 53,373 | 53 K to 53.4 K (+0.75 %) |
Jul 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 50.40 | 396 | 19,958 | 214,032 | 213.6 K to 214 K (+0.19 %) |
Jul 03 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 50.40 | 396 | 19,958 | 234,296 | 233.9 K to 234.3 K (+0.17 %) |
Jun 11 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 51.72 | 20,000 | 1,034,400 | 20,000 | |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.50 | 8,250 | 152,625 | 0 | |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 338,947 | 330.7 K to 338.9 K (+2.49 %) |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 11,369,282 | 11.4 M to 11.4 M (+0.07 %) |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 1,778,613 | 1.8 M to 1.8 M (+0.47 %) |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 52,339 | 44.1 K to 52.3 K (+18.71 %) |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 212,998 | 204.7 K to 213 K (+4.03 %) |
Mar 12 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.50 | 8,250 | 152,625 | 233,262 | 225 K to 233.3 K (+3.67 %) |
Oct 03 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 32.09 | 622 | 19,960 | 330,113 | 329.5 K to 330.1 K (+0.19 %) |
Oct 03 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 32.09 | 622 | 19,960 | 11,360,448 | 11.4 M to 11.4 M (+0.01 %) |
Oct 03 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 32.09 | 622 | 19,960 | 1,769,779 | 1.8 M to 1.8 M (+0.04 %) |
Oct 03 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 32.09 | 622 | 19,960 | 43,505 | 42.9 K to 43.5 K (+1.45 %) |
Oct 03 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 32.09 | 622 | 19,960 | 204,164 | 203.5 K to 204.2 K (+0.31 %) |
Oct 03 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 32.09 | 622 | 19,960 | 224,428 | 223.8 K to 224.4 K (+0.28 %) |
Jun 20 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 31.53 | 20,000 | 630,600 | 20,000 | |
Jun 01 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.13 | 8,250 | 149,573 | 0 | |
Jun 01 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.13 | 8,250 | 149,573 | 0 | |
Jun 01 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.13 | 8,250 | 149,573 | 0 | |
Jun 01 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.13 | 8,250 | 149,573 | 0 | |
Jun 01 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.13 | 8,250 | 149,573 | 0 | |
Jun 01 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 18.13 | 8,250 | 149,573 | 0 | |
Jun 01 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.13 | 8,250 | 149,573 | 328,877 | 320.6 K to 328.9 K (+2.57 %) |
Jun 01 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.13 | 8,250 | 149,573 | 11,359,212 | 11.4 M to 11.4 M (+0.07 %) |
Jun 01 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.13 | 8,250 | 149,573 | 1,768,543 | 1.8 M to 1.8 M (+0.47 %) |
Jun 01 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.13 | 8,250 | 149,573 | 42,269 | 34 K to 42.3 K (+24.25 %) |
Jun 01 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.13 | 8,250 | 149,573 | 202,928 | 194.7 K to 202.9 K (+4.24 %) |
Jun 01 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Buy | M | 18.13 | 8,250 | 149,573 | 223,192 | 214.9 K to 223.2 K (+3.84 %) |
Apr 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 31.49 | 634 | 19,965 | 320,627 | 320 K to 320.6 K (+0.20 %) |
Apr 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 31.49 | 634 | 19,965 | 11,350,962 | 11.4 M to 11.4 M (+0.01 %) |
Apr 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 31.49 | 634 | 19,965 | 1,760,293 | 1.8 M to 1.8 M (+0.04 %) |
Apr 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 31.49 | 634 | 19,965 | 34,019 | 33.4 K to 34 K (+1.90 %) |
Apr 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 31.49 | 634 | 19,965 | 194,678 | 194 K to 194.7 K (+0.33 %) |
Apr 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 31.49 | 634 | 19,965 | 214,942 | 214.3 K to 214.9 K (+0.30 %) |